Insight Molecular Diagnostics (IMDX) Free Cash Flow (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Free Cash Flow of -$8.3 million for Q1 2026, down 17.48% sequentially from -$7.0 million in Q4 2025, and down 34.27% YoY from -$12.6 million in Q1 2025.
Insight Molecular Diagnostics (IMDX) Free Cash Flow (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 12 years of Free Cash Flow data on file, last reported at -$8.3 million in Q1 2026.
- Quarterly Free Cash Flow fell 34.27% year-over-year to -$8.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$27.5 million (down 16.93% YoY) and the FY2025 annual result came in at -$25.4 million, down 19.64% from the prior year.
- Free Cash Flow retreated to -$8.3 million in Q1 2026 per IMDX's latest filing, from -$7.0 million in the prior quarter.
- The five-year high for Free Cash Flow was -$3.2 million in Q3 2023, with the low at -$14.8 million in Q1 2022.
- Average Free Cash Flow over 5 years is -$7.5 million, with a median of -$6.6 million recorded in 2025.
- Year-over-year, Free Cash Flow surged 73.85% in 2023 and tumbled 75.26% in 2024.
- Insight Molecular Diagnostics' Free Cash Flow stood at -$10.4 million in 2022, then surged by 55.14% to -$4.7 million in 2023, then retreated by 18.71% to -$5.6 million in 2024, then slipped by 26.22% to -$7.0 million in 2025, then slipped by 17.48% to -$8.3 million in 2026.
- Business Quant data shows IMDX's Free Cash Flow at -$8.3 million in Q1 2026, -$7.0 million in Q4 2025, and -$5.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -42.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 816.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.09 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 257.97 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 18.03 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 201.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 491.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 122.38 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | -8.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.25 Mn |
| Mar 31, 2026 | -8.25 Mn |
| Dec 31, 2025 | -7.02 Mn |
| Dec 31, 2025 | -7.02 Mn |
| Sep 30, 2025 | -5.55 Mn |
| Sep 30, 2025 | -5.55 Mn |
| Jun 30, 2025 | -6.65 Mn |
| Jun 30, 2025 | -6.65 Mn |
| Mar 31, 2025 | -6.15 Mn |
| Mar 31, 2025 | -6.15 Mn |
| Dec 31, 2024 | -5.57 Mn |
| Dec 31, 2024 | -5.57 Mn |
| Sep 30, 2024 | -5.62 Mn |
| Sep 30, 2024 | -5.62 Mn |
| Jun 30, 2024 | -6.17 Mn |
| Jun 30, 2024 | -6.17 Mn |
| Mar 31, 2024 | -3.85 Mn |
| Mar 31, 2024 | -3.85 Mn |
| Dec 31, 2023 | -4.69 Mn |
| Dec 31, 2023 | -4.69 Mn |